Risk Reduction Solutions for
Pharmaceutical, Life Sciences & Healthcare
News & Events
News
Ecolab’s Bioquell HPV-AQ 35% hydrogen peroxide approval written into European law
Earlier this year, Ecolab’s Bioquell HPV-AQ 35% hydrogen peroxide disinfectant received an approval opinion from the European Chemicals Agency (ECHA) Biocidal Products Committee (BPC) for a Union Authorisation.
We are pleased to communicate that the approval has been officially published in the Official Journal of the European Union and thus written into European law, with Bioquell HPV-AQ given the approval number EU-0027469-0000.
Preparing for lasting challenges of COVID-19
Click here to download the PDF version of this story from the Clinical Services Journal. Due to pressures from highly contagious pathogens, healthcare facilities are seeking all-inclusive offerings to handle decontamination responsibilities and discovering unique solutions for creating private patient areas. Measures to help slow the spread of healthcare-associated infections (HCAIs), including COVID-19, require a […]
Read More
Higher Hygiene Standards for Infection Control
In this Clinical Services Journal article, the topic of innovative decontamination efforts and hand hygiene tools are reviewed to show how they have helped hospitals raise infection control standards during the pandemic. Hospitals across the world saw cases rise while also dealing with unique challenges, whether PPE shortages, supply and staff issues, or finding effective […]
Read More
Bioquell Helping Pharmaceutical Companies Resume Operations Post COVID-19
Bioquell Rapid Bio Decontamination Service (RBDS) enables businesses to quickly regain control of clean spaces and ramp up capacity As the world prepares to enter the next phase of the COVID-19 pandemic with the potential relaxation of lockdown restrictions, Bioquell, an Ecolab solution and leading manufacturer of high performance bio-decontamination technology, is utilizing its well-proven […]
Read More
Bioquell Rapid Bio-decontamination Service Helps Eliminate Spores in a Major Pharmaceutical Manufacturing Facility in Wuhan, China
Following the COVID-19 lockdown, environmental monitoring at a major international provider of Biologics Contract Development and Manufacturing Organisations (CDMO) services in Wuhan, China indicated spore contamination in a production room. Despite exhausting all disinfection methods in its records, including the manual application of a sporicide, there was a repeated failure of the EM test standards. […]
Read More
